High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

Stopped Moderna Bivalent COVID-19 Vaccine became available to the public in Sept 2022.

Conditions

• Lung Transplant Recipient
• SARS-CoV-2
• Immunosuppression

Interventions

• DRUG: mRNA-1273 (Moderna COVID-19 vaccine)

Sponsor

University of California, Los Angeles

Collaborators

• [object Object]